Skip to main content

Global Metabolic Analyses of Acinetobacter baumannii

  • Protocol
  • First Online:
Acinetobacter baumannii

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1946))

Abstract

Acinetobacter baumannii is rapidly emerging as a multidrug-resistant pathogen responsible for nosocomial infections including pneumonia, bacteremia, wound infections, urinary tract infections, and meningitis. Metabolomics provides a powerful tool to gain a system-wide snapshot of cellular biochemical networks under defined conditions and has been increasingly applied to bacterial physiology and drug discovery. Here we describe an optimized sample preparation method for untargeted metabolomics studies in A. baumannii. Our method provides a significant recovery of intracellular metabolites to demonstrate substantial differences in global metabolic profiles among A. baumannii strains.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48(1):1–12

    Article  Google Scholar 

  2. World Health Organization (WHO) (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Available at: http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/. Accessed 10 Dec 2018

  3. Fishbain J, Peleg AY (2010) Treatment of Acinetobacter infections. Clin Infect Dis 51(1):79–84

    Article  Google Scholar 

  4. Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5(12):939–951

    Article  CAS  Google Scholar 

  5. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21(3):538–582

    Article  CAS  Google Scholar 

  6. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL (2006) Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 6(9):589–601

    Article  CAS  Google Scholar 

  7. Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD (2015) Framework for optimization of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis 15(2):225–234

    Article  CAS  Google Scholar 

  8. Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N (2011) Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother 55(7):3370–3379

    Article  CAS  Google Scholar 

  9. Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, Hancock RE (2011) The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother 55(8):3743–3751

    Article  CAS  Google Scholar 

  10. Pelletier MR, Casella LG, Jones JW, Adams MD, Zurawski DV, Hazlett KR, Doi Y, Ernst RK (2013) Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 57(10):4831–4840

    Article  CAS  Google Scholar 

  11. Moffatt JH, Harper M, Harrison P, Hale JDF, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD (2010) Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 54(12):4971–4977

    Article  CAS  Google Scholar 

  12. Chen C, Gonzalez FJ, Idle JR (2007) LC-MS-based metabolomics in drug metabolism. Drug Metab Rev 39(2–3):581–597

    Article  CAS  Google Scholar 

  13. Mastrangelo A, Armitage EG, Garcia A, Barbas C (2014) Metabolomics as a tool for drug discovery and personalised medicine. A review. Curr Top Med Chem 14(23):2627–2636

    Article  CAS  Google Scholar 

  14. Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17(7):451–459

    Article  CAS  Google Scholar 

  15. Theodoridis G, Gika HG, Wilson ID (2008) LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. TrAC-Trends Anal Chem 27(3):251–260

    Article  CAS  Google Scholar 

  16. Patti GJ, Yanes O, Innovation SG (2012) Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13(4):263–269

    Article  CAS  Google Scholar 

  17. Mahamad Maifiah MH, Cheah SE, Johnson MD, Han ML, Boyce JD, Thamlikitkul V, Forest A, Kaye KS, Hertzog P, Purcell AW, Song J, Velkov T, Creek DJ, Li J (2016) Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii. Sci Rep 6:22287

    Article  CAS  Google Scholar 

  18. Zhang T, Creek DJ, Barrett MP, Blackburn G, Watson DG (2012) Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with Orbitrap mass spectrometry for metabolomic studies of human urine. Anal Chem 84(4):1994–2001

    Article  CAS  Google Scholar 

  19. Creek DJ, Jankevics A, Burgess KE, Breitling R, Barrett MP (2012) IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data. Bioinformatics 28(7):1048–1049

    Article  CAS  Google Scholar 

  20. Gika HG, Theodoridis GA, Wingate JE, Wilson ID (2007) Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J Proteome Res 6(8):3291–3303

    Article  CAS  Google Scholar 

Download references

Acknowledgments

Jian Li, Darren J. Creek, and Tony Velkov are supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01 AI111965 and AI132681 [JL and TV]). Mohd Hafidz Mahamad Maifiah is an academic staff from the International Institute for Halal Research and Training (INHART), International Islamic University Malaysia (IIUM). Darren J. Creek and Tony Velkov are Australian National Health and Medical Research Council (NHMRC) Dareer Development Fellows. Jian Li is an Australian NHMRC Senior Research Fellow.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian Li .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Mahamad Maifiah, M.H., Velkov, T., Creek, D.J., Li, J. (2019). Global Metabolic Analyses of Acinetobacter baumannii. In: Biswas, I., Rather, P. (eds) Acinetobacter baumannii. Methods in Molecular Biology, vol 1946. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9118-1_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9118-1_28

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-9117-4

  • Online ISBN: 978-1-4939-9118-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics